Medtronic and Brainomix Join Forces to Deliver Faster, Smarter Stroke Care with AI-Powered Imaging
February 27, 2025 – Western Europe – In a major development for neurovascular medicine, Medtronic Neurovascular, a global leader in medical technology, has announced a strategic partnership with Brainomix, a pioneering AI imaging company focused on stroke diagnostics. The collaboration aims to revolutionize stroke care across Western Europe by integrating Brainomix’s intelligent imaging software with Medtronic’s portfolio of stroke treatment technologies.
Brainomix 360 Stroke Platform Brings Real-Time AI to Clinical Decisions
The centerpiece of this partnership is the Brainomix 360 Stroke platform—an AI-powered system designed to analyze brain scans and support treatment decisions in real time. This platform has already proven its clinical value in what is considered the largest real-world stroke AI evaluation to date, analyzing data from over 450,000 patients in England. Notably, sites using Brainomix AI saw thrombectomy rates double, with a further 37% increase compared to non-AI-supported sites.
Combining Imaging Intelligence with Medtronic’s Neurovascular Devices
By combining Brainomix’s cutting-edge diagnostics with Medtronic’s advanced tools for treating ischemic stroke, the partnership is set to optimize stroke pathways. Clinicians will gain earlier access to critical information, enabling quicker interventions and improved patient outcomes across the region.
Leadership Voices Support the AI Vision
Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix, expressed strong alignment between the two organizations:
“This is a natural partnership—uniting the leading stroke AI imaging platform with the leading neurovascular device company. Together, we can reshape stroke care delivery in Europe by ensuring faster, AI-guided decisions that translate into more lives saved.”
Matt Sturt, Vice President of Medtronic Neurovascular, Western Europe, emphasized the impact of collaboration:
“By fusing Medtronic’s proven devices with Brainomix’s imaging intelligence, we aim to accelerate diagnosis, reduce delays, and ensure patients across Europe have access to the best possible stroke treatment.”
Clinical Experts Highlight Real-World Benefits
Dr. Alex Solich, Senior Consultant at Karolinska and Örebro Hospitals, shared the frontline perspective:
“Speed and precision are everything in stroke care. The synergy between Medtronic’s technology and Brainomix’s software will allow us to act faster and smarter—ultimately improving outcomes for countless patients.”
Key Partnership Highlights
- Expanding Regional Access: Medtronic’s distribution network will facilitate rapid adoption of Brainomix AI in stroke centers across Western Europe.
- Enhanced Accuracy: Clinicians will gain access to precise, real-time diagnostic tools—improving confidence and consistency in treatment decisions.
- Workflow Efficiency: Streamlined imaging and intervention support will help reduce delays, lessen healthcare burdens, and maximize recovery opportunities.
This partnership is a pivotal step toward a future where stroke care is faster, more connected, and guided by AI at every decision point.
By
